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Case Report: 
 
An 11-year old male hemodialysis patient developed a firm, painless mass on the right 
nasal bridge of insidious onset that gradually increased in size involving the left nasal 
bridge and the left mandible over 2-year duration, with difficulty in chewing (figure 1). 
 
He had an underlying diagnosis of CAKUT with posterior-urethral valve and an absent 
left kidney. At 4-years of age, he commenced renal replacement therapy in the form of 
peritoneal dialysis (PD). This was complicated by recurrent peritonitis, catheter blockage 
and displacement which required change in modality to hemodialyis at 4 and a half years 
of age, with three sessions per week (12-hours/week). 
 
He had severe growth failure (height SDS - 4.3) and commenced recombinant human 
growth hormone at 2-years of age. Growth hormone was continued for 8 years but he 
remained below the 3th percentile (height SDS - 3.3 at 11 years of age) 
 
He developed chronic bone pain, with slowly progressive long bone deformities. He 
became confined to a wheel chair at 6-years of age. Besides hemodialysis, he was 
treated with bicarbonate to control his acid-base balance along with phosphate binders 
(sevelamer), 1-alpha hydroxylated vitamin D3 (orally and intravenously), and lastly 
calcimimetics (Cinacalcet), which was started at 10-years of age, resulting in cessation 
of tumor growth without regression in size. Table 1. give’s summary of his bone profile 
and creatinine across the years.  
 
Till the date of writing this quiz, the child is receiving regular hemodialysis sessions, with 
no apparent improvement in the biochemical markers or regression of the tumor size. 
 
Age (years) 
Normal 
Values 
6 7 8 9 10 11 
Calcium 
(mmol/l) 
2.12-2.52 
2.36 
(2.02-2.57) 
2.28 
(1.84-2.59) 
2.28 
(1.98-2.71) 
2.4 
(1.97-2.31) 
2.2 
(1.97-2.37) 
2.28 
(2.04-2.66) 
Phosphate 
(mmol/l) 
0.81–1.58 
2.05 
(1.10-3.1) 
2.7 
(1.4-3.88) 
1.86 
(1.11-3.7) 
1.71 
(0.92-2.87) 
2.89 
(2.01-3.61) 
2.8 
(2.03-3.39) 
Alkaline 
phosphatase  
(IU/l) 
 
150-360 
234 
(203-266) 
333 
(205-432) 
530 
(277-721) 
859 
(680-1194) 
504 
(388-694) 
363 
(298-410) 
PTH  
(pmol/I) 
1.6-6.9 
131 
(108-154) 
195 
(117-295) 
241 
(55-401) 
211 
(77-287) 
240 
(198-274) 
201 
(201) 
Albumin  
(gm/l) 
 
34–50 
21 
(10-32) 
31 
(27-35) 
31 
(28-35) 
32 
(30-35) 
28 
(31-34) 
30 
(27-34) 
Creatinine 
(mmol/l) 
 
35–62 
491 
(259-737) 
527 
(257-834) 
535 
(199-865) 
445 
(182-795) 
440 
(241-729) 
516 
(228-837) 
Bicarbonate 
(mmol/l) 
22-26 19 16 22 18 23 17 
Kt/V >1.2 
 
1.5 
(1.39-1.59) 
 
1.49 
(1.32-1.79) 
 
1.66 
(1.46-1.9) 
 
1.6 
(1.34-1.79) 
 
1.45 
(1.08-1.75) 
 
 
1.22 
(1.10-1.32) 
 
 
 
 
 
 
 
 
 
Questions: 
 
1. Describe the findings In the computed tomography (CT)? 
2. What is your diagnosis? 
3. How would you manage this case? 
4. What is the role of cinacalcet in managing this case? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Photo of the child, computed 
tomography (CT) reconstruction and two 
CT slices  
